To compare the effect of two Ayurveda medicines (Saptasama Yoga and Amritbhallataka Avaleha) after therapeutic detoxification (through anal route) in patients of Psoriasis (skin disorder)

Efficacy of Saptasama Yoga after Virechana over Amritbhallataka Avaleha after Virechana in the Management of Kitibha Kushtha (Plaque Psoriasis)-An Open Labelled Randomized Comparative Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080409

Enrollment

Registered

2025-02-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age- 18- 60 years, irrespective of sex, religion, occupation. 2. Patients having clinical features of Kitibha Kushtha- Shyavam, Kinakhara Sparsha, Parusham, Ruksha, Kandu SN4A (ICD-11 Traditional medicine Module 2) (Plaque Psoriasis), ICD-11 Psoriasis EA90 3. Patients who are Snehana, Swedana and Virechana Yogya. 4. Patients having Madhyama or Pravara Shuddhi will be considered for oral intervention. 5. Able and willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1. Lactating and pregnant women, Patients addicted to alcohol. 2. Patients suffering from diseases like uncontrolled Diabetes, HTN, Renal, Liver disease, CAD, IHD, Cancer, AIDS. 3. Patients showing complications of psoriasis like erythrodermic (EA90.3) or pustular psoriasis (EA90.4), Psoriatic arthropathy with deformity. 4. Patients having pitta prakriti. 5. Patients who are allergic to any of the ingredients of interventional drugs.

Design outcomes

Primary

Measure	Time frame
Reduction in the Psoriasis Area Severity Index (PASI) score. Reduction in clinical manifestation of Kitibha Kushta (Plaque Psoriasis) - shyava, kinakharasparsha, ruksha, parusha, kandu. Timepoint: 3 time points- Baseline After 6 weeks of oral medicine Ater followup of 6 weeks	—

Secondary

Measure	Time frame
Alteration of blood-count derived inflammatory markers in psoriasis. Improvement in the Psoriasis Disability Index (PDI). Dermatology Life Quality Index (DLQI) Psoriasis Life Stress Inventory Scale (PLSI) Perceived Stress Scale (PSS) Timepoint: Blood markers will be assessed at baseline and after treatment of 6 weeks all scales will be assessed baseline, after 6 weeks of medicine and after follow-up	—

Measure

Time frame

Alteration of blood-count derived inflammatory markers in psoriasis. Improvement in the Psoriasis Disability Index (PDI). Dermatology Life Quality Index (DLQI) Psoriasis Life Stress Inventory Scale (PLSI) Perceived Stress Scale (PSS) Timepoint: Blood markers will be assessed at baseline and after treatment of 6 weeks all scales will be assessed baseline, after 6 weeks of medicine and after follow-up

—

Countries

India

Contacts

Public ContactPROF DR JONAH S

ALL INDIA INSTITUTE OF AYURVEDA

jonahdr@gmail.com9448262298

Outcome results